Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on News Break! Middle East.
Press releases published on July 7, 2025
Synfini Adds $8.9 Million Discovery Funding to Speed Small Molecule Drug Development
GlobeNewswire
·
July 7, 2025
MENLO PARK, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Synfini, Inc., a trailblazer in AI-driven chemistry automation, today announced a $8.9 million expansion of its round, led by JSL Health Capital and supported by a strong syndicate of early-stage …
Inspira in High-Level Government Talks to Advance National Integration of the ART100 and Establish a Global Distribution Framework
GlobeNewswire
·
July 7, 2025
RA'ANANA, Israel, July 07, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira," “Inspira Technologies,” or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced that it is …
SELLAS Life Sciences Appoints Linghua Wang, MD, PhD, to Scientific Advisory Board
GlobeNewswire
·
July 7, 2025
NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …
Ripplecoin Mining cloud mining application is changing the way Ripple (XRP), Bitcoin (BTC), Solana holders make money
GlobeNewswire
·
July 7, 2025
San Francisco, California, July 07, 2025 (GLOBE NEWSWIRE) -- Today's cryptocurrency market is volatile, and more and more XRP, BTC and Solana holders are looking for investment methods that do not rely on market fluctuations and can bring sustainable …
ParaZero Successfully Achieved 100% Effectiveness Against Fast-Incoming Drone Threats in Live Field Demonstration
GlobeNewswire
·
July 7, 2025
The Live Field Demo with the Company’s DefendAir System was Showcased to Senior Israeli Defense Leadership Kfar Saba, Israel, July 07, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace company …
Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025
GlobeNewswire
·
July 7, 2025
Planned submission of IND application in 2025; Phase 1 clinical trial to follow if IND application approved No new PTSD drug approvals in the U.S. in nearly 25 years; large potential addressable market for SPC-15 worldwide SARASOTA, FL, July 07, 2025 ( …
Foresight: Eye-Net and Leading European Vehicle Manufacturer Successfully Advance Vehicle Safety with First-Phase Testing
GlobeNewswire
·
July 7, 2025
The POC project aims to integrate Eye-Net’s technology into the safety systems of the vehicle manufacturer’s vehicles, creating a comprehensive ecosystem that connects the vehicle, vulnerable road users, and surrounding infrastructure for enhanced …
Medical Supplierz Expands Global Access to Leading Medical Manufacturers
EIN Presswire
·
July 7, 2025
KUWAIT, KUWAIT, July 7, 2025 /EINPresswire.com/ -- Medical Supplierz, a digital B2B procurement platform, has launched new initiatives to strengthen global connectivity between verified healthcare buyers and trusted medical manufacturers. The platform …
Vortex Energy Announces ANT Survey Sampling Plan for Robinsons River Salt Project
GlobeNewswire
·
July 7, 2025
VANCOUVER, British Columbia, July 07, 2025 (GLOBE NEWSWIRE) -- Vortex Energy Corp. (CSE: VRTX) (OTC: VTECF) (FSE: AA3) (“Vortex” or the “Company”) is pleased to announce the finalized sampling plan for the Ambient Noise Tomography (ANT) geophysical survey …
UroGen Announces Completion of Enrollment in the Phase 3 UTOPIA Clinical Trial of UGN-103 for the Treatment of Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
GlobeNewswire
·
July 7, 2025
PRINCETON, N.J., July 07, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it has completed …
Medicines for Poland Announces: Without pharmaceutical factories Europe will lose any war
GlobeNewswire
·
July 7, 2025
BRUSSELS, July 07, 2025 (GLOBE NEWSWIRE) -- The need to establish a fund under the EU budget to support the production of critical medicines in Europe is a conclusion drawn from an analysis of the impact of the war on the availability of medicines in …
HUB Cyber Security (Nasdaq: HUBC) Appoints Aviv Eyal to Lead AI-Native Digital Asset Infrastructure Division
GlobeNewswire
·
July 7, 2025
TEL AVIV, Israel, July 07, 2025 (GLOBE NEWSWIRE) -- HUB Cyber Security Ltd. (Nasdaq: HUBC) (“HUB” or the “Company”), a global leader in zero-trust confidential computing, secured data fabric infrastructure and AI-native security orchestration, today …
Onco360 Has Been Selected as a National Specialty Pharmacy for Augtyro™ (repotrectinib)
GlobeNewswire
·
July 7, 2025
LOUISVILLE, Ky., July 07, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent specialty pharmacy, has added Augtyro™ (repotrectinib) manufactured by Bristol Myers Squibb to its comprehensive list of limited distribution therapies. Augtyro …
Redevances OR annonce les livraisons préliminaires d’onces d’équivalent d’or pour le deuxième trimestre de 2025 et des produits trimestriels et une marge monétaire records
GlobeNewswire
·
July 7, 2025
MONTRÉAL, 07 juill. 2025 (GLOBE NEWSWIRE) -- Redevances OR Inc. (la « Société » ou « Redevances OR ») (TSX et NYSE : OR) a le plaisir de fournir une mise à jour sur ses livraisons, ses produits et sa marge monétaire préliminaires pour le deuxième trimestre …
OR Royalties Announces Preliminary Q2 2025 GEO Deliveries Along with Record Quarterly Revenue & Cash Margin
GlobeNewswire
·
July 7, 2025
MONTRÉAL, July 07, 2025 (GLOBE NEWSWIRE) -- OR Royalties Inc. (“OR Royalties” or the “Company”) (OR: TSX …
Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis
GlobeNewswire
·
July 7, 2025
-- Patients treated with bezuclastinib showed a superior mean change in total symptom score at 24 weeks (-24.3 points vs. -15.4 points, -8.91 point placebo-adjusted difference; p=0.0002), compared to patients treated with placebo, establishing new …
BioCryst Appoints Babar Ghias Chief Financial Officer and Head of Corporate Development
GlobeNewswire
·
July 7, 2025
RESEARCH TRIANGLE PARK, N.C., July 07, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the appointment of Babar Ghias as chief financial officer (CFO) and head of corporate development. Mr. Ghias joins BioCryst from …
Aya Gold & Silver Reports High-Grade Boumadine Exploration Results, Expands Imariren to 1km and Identifies New High-Grade Asirem Zone to the West
GlobeNewswire
·
July 7, 2025
MONTREAL, July 07, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce new high-grade drill exploration results from its 2025 program at Boumadine in the Kingdom of Morocco. Today's …
Aya Or & Argent inc. publie des résultats d’exploration à haute teneur à Boumadine, augmente l’étendue de la zone Imariren à 1 km et identifie la zone Asirem, une nouvelle zone à haute teneur à l’ouest
GlobeNewswire
·
July 7, 2025
MONTRÉAL, 07 juill. 2025 (GLOBE NEWSWIRE) -- Aya Or & Argent inc. (TSX : AYA; OTCQX : AYASF) (« Aya » ou la « Société ») a le plaisir d’annoncer les nouveaux résultats de forage d’exploration à haute teneur issus de son programme 2025 à Boumadine, dans le …
Lancaster Strengthens Gold Portfolio with Completion of Lake Cargelligo Acquisition
GlobeNewswire
·
July 7, 2025
VANCOUVER, British Columbia, July 07, 2025 (GLOBE NEWSWIRE) -- Lancaster Resources Inc. (CSE:LCR) (OTC Pink:LANRF) (FRA:6UF0) (“Lancaster”, the “Company”) is pleased to announce the completion of its acquisition of 100% of the Lake Cargelligo Gold Project, …